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Degenerative Encephalopathy in Nova Scotia Duck Tolling
Retrievers Presenting with a Rapid Eye Movement Sleep Behavior
Disorder
E.N. Barker, L.J. Dawson, J.H. Rose, S. Van Meervenne, O. Frykman, C. Rohdin, A. Leijon,
K.E. Soerensen, J. J€arnegren, G.C. Johnson, D.P. O’Brien, and N. Granger
Background: Neurodegenerative diseases are a heterogeneous group of disorders characterized by loss of neurons and are
commonly associated with a genetic mutation.
Hypothesis/Objectives: To characterize the clinical and histopathological features of a novel degenerative neurological dis-
ease aﬀecting the brain of young adult Nova Scotia Duck Tolling Retrievers (NSDTRs).
Animals: Nine, young adult, related NSDTRs were evaluated for neurological dysfunction and rapid eye movement sleep
behavior disorder.
Methods: Case series review.
Results: Clinical signs of neurological dysfunction began between 2 months and 5 years of age and were progressive in nat-
ure. They were characterized by episodes of marked movements during sleep, increased anxiety, noise phobia, and gait abnor-
malities. Magnetic resonance imaging documented symmetrical, progressively increasing, T2-weighted image intensity,
predominantly within the caudate nuclei, consistent with necrosis secondary to gray matter degeneration. Abnormalities were
not detected on clinicopathological analysis of blood and cerebrospinal ﬂuid, infectious disease screening or urine metabolite
screening in most cases. Postmortem examination of brain tissue identiﬁed symmetrical malacia of the caudate nuclei and axonal
dystrophy within the brainstem and spinal cord. Genealogical analysis supports an autosomal recessive mode of inheritance.
Conclusions and Clinical Importance: A degenerative encephalopathy was identiﬁed in young adult NSDTRs consistent
with a hereditary disease. The prognosis is guarded due to the progressive nature of the disease, which is minimally respon-
sive to empirical treatment.
Key words: Axonopathy; Basal nuclei; Behavioral changes; Familial.
Neurodegenerative diseases occur in both humansand animals.1,2 They form a large heterogeneous
group of diseases characterized by loss of neurons
leading to distinct involvement of functional systems,
mostly caused by a genetic anomaly.3–5 Clinical signs
are often progressive, possibly delayed in onset, and
reﬂect the area(s) of the central nervous system most
aﬀected. The end result of these diseases might be
encephalomalacia, which is a nonspeciﬁc ﬁnding charac-
terized by a hyperintense signal on T2-weighted mag-
netic resonance imaging (MRI) as a result of ﬂuid
accumulation. Although rapid eye movement (REM)
sleep behavior disorders are a common ﬁnding in
human neurodegenerative diseases such as Parkinson’s
disease, multiple systems atrophy, and dementia with
Lewy bodies,6,7 sleep disorders have not been asso-
ciated with neurodegenerative diseases in dogs.8–10
Neurologists in the United Kingdom, Canada, and
Sweden have recently recognized the emergence of a novel
degenerative encephalopathy in the Nova Scotia Duck
Tolling Retriever (NSDTR), presenting with progressive
neurological dysfunction including REM sleep behavior
disorder, not previously reported in dogs. The purpose of
this study was to characterize the phenotype and potential
etiology of this condition to provide the basis for elimina-
tion of the disease in the NSDTR population.
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Materials and Methods
From 2013 to 2014, 9 purebred NSDTR located in United
Kingdom, Canada, and Sweden were investigated for slowly pro-
gressive neurological dysfunction. Clinical and historical informa-
tion regarding these dogs were obtained by medical record review
and consultation with owners and referring veterinarians. Com-
plete blood counts, routine serum biochemistry proﬁles, brain
MRI, cerebrospinal ﬂuid (CSF) analysis, infectious disease screen-
ing (serology or PCR for Toxoplasma gondii, Neospora caninum,
and canine distemper virus), and urine metabolic screening were
performed in various animals at the discretion of the neurologist
conducting each case work-up and reviewed where available.
After euthanasia due to progressive clinical signs, postmortem
examination was performed in 3 dogs, and light microscopy
histopathological studies of brain, muscles, and other tissues were
performed on collected samples. The brain of a 15-year-old, neu-
tered male NSDTR that was euthanized as a result of choroid
plexus carcinoma and lacked microscopic lesions seen in aﬀected
dogs was also examined as a control. The familial relationship
between this dog and aﬀected dogs is unknown. Tissues were ﬁxed
by immersion in neutral buﬀered formalin, embedded in paraﬃn,
and sectioned at 5 lm thickness. Sections were stained with hema-
toxylin and eosin (H&E), Bielschowsky silver stain for cell pro-
cesses, Perl’s stain for iron, and luxol fast blue stain for myelin.
Immunohistochemical staining was performed on selected sections
to detect the following factors: neuroﬁlament proteins in axons;
neuronal calcium-binding proteins calbindin, calretinin, and par-
valbumin in selected populations of neurons; NeuN in neurons;
and glial ﬁbrillary acidic protein (GFAP) in astroglia (for methods
used with immunohistochemical reagents see Table S1).11–13
To determine the genealogical relationships among aﬀected
dogs, data were collected either from pedigree information
provided by the dog owners or accessed through public canine
registries.ab
Results
Case Histories/Clinical Findings/Response to
Treatment
These data are available for individual dogs in
Table S2.
Clinical signs were reported in dogs 2 months to
5 years of age, were progressive in nature, and were simi-
lar in all cases. The most consistent clinical sign was a
REM sleep behavior disorder characterized by frequent
episodes of marked involuntary movements during sleep
(see Video S1). These episodes of involuntary movements
were both extreme and progressive over time, in contrast
to the sleep movements of clinically normal dogs. The
observed episodes were violent and owners of aﬀected
dogs reported that the dogs had fallen from their bed and
owners were awakened by the agitation of the dog. The
duration of episodes typically ranged from a few seconds
to 15–30 minutes, although some owners reported occa-
sional episodes lasting longer than 1 hour and occurred
up to 10 times in a sleep period. The dogs made running
movements, sometimes lifting their heads, and frequently
vocalized. Some owners also reported that the dog would
be diﬃcult to awaken from sleep.
The dogs learned basic obedience, but had diﬃculty
with advanced training. Aﬀected dogs had increased
anxiety and sensitivity to sensory stimuli, which some-
times manifested as noise phobia or obsessive-
compulsive behaviors such as tail chasing, chasing any
moving object, or repeatedly investigating their food
bowl. With progression of the disease 4 dogs began
having aggressive interactions (#4,5,7,9), or lacked self-
control, with other dogs and sometimes their owners.
Five owners reported abnormal swimming motion
(#4,5,7–9; the dog adopting a vertical position in water
—see Video S2), whereas others felt this was part of
normal learning to swim and others were never wit-
nessed swimming. The owners also reported reduced tail
movement and gait abnormalities. Two dogs were
reported to have been urinary and fecally incontinent
(#2,9). To date, 5 dogs (#1,4,7–9) have been euthanized
due to progressive debilitating behavior anomalies.
Abnormalities were not detected on general physical
examination in 7 dogs (#3–9). One dog (#2) had a heart
murmur, although abnormalities were not detected on
subsequent electrocardiography and echocardiography.
One dog (#1) was small in stature and also had a prior
history of reactive lymphadenopathy of unknown etiol-
ogy. One dog (#3) had a prior history of steroid-
responsive meningitis-arteritis (SRMA) and had relapse
of clinical signs (pyrexia, neck pain, and lethargy) con-
comitant with the appearance of the ﬁrst movement
disturbances during sleep.
Neurologically, the majority of dogs were mentally
alert. Aﬀected dogs showed varying degrees of a gener-
alized ataxia and tetraparesis, with mild hypermetria in
the thoracic limbs. A ﬁne head tremor was reported in
1 dog (#1). Mild conscious proprioceptive deﬁcits were
occasionally noted. The tendon reﬂexes were brisk, and
crossed extensor reﬂexes were recorded in 2 dogs (#1,2).
Abnormalities were more exaggerated in the pelvic
limbs in comparison with the thoracic limbs in all but 1
dog (#3). In 1 dog, neurological deﬁcits were lateralized
(#5), while, in the remainder, they were symmetrical. Of
the cranial nerves, mild menace deﬁcits were occasion-
ally reported, as was abnormal vision and strabismus
(#2,3,5). One dog (#1) acutely developed keratoconjunc-
tivitis sicca, suspected to be neurogenic in origin, with
bilateral corneal ulceration, in the absence of an under-
lying cause, and that was poorly responsive to conven-
tional treatment for non-neurogenic keratoconjunctivitis
sicca.
One dog had an equivocal response to anti-epileptic
medication (levetiracetam, imepitoin). Response to cor-
ticosteroids was positive in 1 dog (#2) and resulted in a
progression of behavioral signs in (#3).
Clinical Pathology
Hematology and serum biochemistry results were
available for 6 aﬀected dogs (#1,2,3,5,8,9). Other than 1
dog (#3) with a mild, mature neutrophilia (16.10 9 103/
lL, reference interval 2.95–11.64 9 103/lL) and
increased C-reactive protein (121 mg/L, reference inter-
val 0–35 mg/L) that were attributed to concurrent
SRMA, none of the results were considered remarkable.
Abnormalities were not detected on additional tests,
performed at the discretion of the attending clinician:
bile acid stimulation test (#1), serum cobalamin (#1),
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serum thiamine (#2,3), cisternal CSF analysis (#1,2,4,8),
urine organic metabolites (#1,2,5), ACTH stimulation
test (#1), T. gondii and N. caninum serology (#1,2) and
PCR of CSF (#1), and canine distemper virus PCR of
CSF (#1,2).
Magnetic Resonance Imaging Findings
Magnetic resonance imaging of the brain was per-
formed in 4 dogs (#1,2,3,8). The most striking lesions
were bilateral symmetrical, rounded, T2-weighted
hyperintensities, which were hypointense on FLAIR,
within the caudate nucleus, particularly rostrally
(Fig 1). These lesions intensity did not change on
T1-weighted images after IV injection of gadolinium
contrast agent and compared to precontrast injection
such that no hyperintensity was noted. In addition,
moderately hyperintense lesions forming bands within
the brainstem running from ventrolateral to dorsome-
dial and within the lateral cuneate nuclei, caudal
A
B C D
E F G
Fig 1. MR images from Dog #1. T2-weighted image (A), parasagittal to the right of midline at the level of the caudate nuclei lesions,
showing well-deﬁned hyperintense lesions at age 47 months. Transverse T1-weighted (B), T1-weighted postcontrast (C), and FLAIR
(D) images at the level of caudate nuclei (indicated by red dashed line on parasagittal view) at age 47 months. Transverse T2-weighted
images at the level of caudate nuclei obtained at 30 (E), 37 (F), and 47 months (G), demonstrating progressive cavitation.
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cerebellar peduncles, and spinal tract of the trigeminal
nuclei were also noted on T2-weighted images (Fig 2).
In 1 dog, follow-up MRI performed at intervals of 7
and 17 months after the initial presentation documented
mild progression of these changes (Fig 1E–G).
Postmortem Examination
Postmortem examination was performed in 3 dogs
(#1,8,9). Transverse sectioning of the brain revealed
bilaterally symmetrical cavities in the head of the cau-
date nucleus, corresponding to the changes seen on
MRI, in all dogs examined (Fig 3). Abnormalities were
not detected during the remainder of the postmortem
examinations.
Histopathological Distribution and General
Characteristics of Brain Lesions
All aﬀected dogs had symmetrical cavitatory lesions
at necropsy that aﬀected portions of the caudate
nucleus, as seen grossly (Fig 3). The centers of these
cavitations were unstained, and gitter cells were gener-
ally uncommon, except near tissue margins. The
irregular periphery of the cavitations was crossed by
slender strands of neuropil containing thin-walled, often
patent, blood vessels ensheathed by glia (Fig 4). Irregu-
lar spongiform change loosened the neuropil around the
cavity, with coincident astrocytosis. Neurons remained
in unaﬀected portions of the nuclei. One dog had a tiny
area of iron pigment peripheral to the cavity, but the
other 2 dogs and the unaﬀected NSDTRs were negative
for iron. Cavitation did not aﬀect the brain of the unaf-
fected dog.
In addition to caudate cavitations, all dogs had
prominent swollen, eosinophilic neurites of various sizes
observed with H&E staining (Fig 5A, B), which were
most obvious in the brainstem, cerebellum, and medu-
lla, but which occurred throughout the neuraxis, includ-
ing the spinal cord of the 1 dog examined. These were
present in the internal granular and molecular layers of
the cerebellum and in white matter of cerebellar folia.
However, they were overall most numerous in the cere-
bellar roof nuclei, superior olives, trapezoid, cuneate,
and gracilis nuclei of the medulla and inferior olives
(Fig 5A). In cross section, these swellings measured up
to 50 lm diameter. Longitudinal proﬁles of swollen
axons were apparent in associated white tracts.
A B
Fig 2. MR images from Dog #2. T2-weighted (A) and FLAIR (B) transverse images at the level of the lateral cuneate nuclei showing a
hyperintense signal (red arrow).
Fig 3. Fixed brain tissue sections (upper series; Dog #9) along transverse T2-weighted MR images (lower series; Dog #2) moving rostrally
from the level of the pituitary gland, illustrating the homogeneity of the disease among cases. Symmetrical cavitatory lesions are visualized
in portions of the caudate nuclei, corresponding to the hyperintense lesions seen on T2-weighted magnetic resonance imaging.
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Droplet-like swollen neurites were found at low density
in the thalamus, hippocampus, striate nuclei, cochlear
nuclei, and colliculi (Fig 5B).
Immunohistochemistry for Neurons and Their
Projections
Bielschowsky and phosphorylated neuroﬁlament
stains were used to identify nerve ﬁbers and NeuN to
identify neuronal cell bodies. Calcium-binding protein
stains were used because they stain both the soma and
cell processes. Swollen neurites had 2 relatively distinct
morphologies. Smaller homogeneous deeply eosinophi-
lic, droplet-like swellings were more common in the
forebrain and did not stain with Bielschowsky stains.
Larger swellings had rounded to somewhat irregular,
lumpy shapes and stained heterogeneously pale to
intensely eosinophilic with H&E and variably with
Bielschowsky stains (Fig 5A, C). In a few areas,
rosettes of small, rounded neurites were clustered
around neurons, forming a halo around the soma
(Fig 5D). Rarely, continuity could be observed
between axonal swellings and a nucleated nerve cell
body (Fig 5C, inset). NeuN immunohistochemistry of
specimens containing numerous swollen axons revealed
the continued presence of at least some nerve cell bod-
ies (Fig 5D, inset) despite the neurite/axonal changes.
The larger dilations in the hindbrain were often irregu-
larly positive for expression of phosphorylated neuroﬁl-
aments, which identiﬁes axons with relative speciﬁcity
(Fig 5E). Phosphorylated neuroﬁlament staining was
not found in nerve cell bodies, as expected in normal
brain. Phosphorylated neuroﬁlaments were not detected
in the smaller swellings in the forebrain. Calcium-bind-
ing proteins were utilized to examine the morphology
of several populations of neurons in the cerebellum
and brainstem (Fig 5F). Staining of these soluble
proteins was more homogeneous than staining of neu-
roﬁlaments using immunohistochemistry or the
Bielschowsky method. They also veriﬁed the presence
of swollen neurites in white matter and nuclei, as both
the soma and cell processes stain with these reagents.
The calcium-binding proteins immunohistochemistry
appeared normal.
Immunohistochemistry for Astrocytes
Astrocytes were examined with immunohistochem-
istry using GFAP staining. Degenerative changes in
neurites were frequently associated with profound
enlargement of astrocytes in aﬀected brainstem areas.
Astrocytes often had gemistocytic morphology and
greatly enlarged nuclei and were intimately associated
with neurons and swollen axons (Fig 6).
Histopathology of Other Organs/Parts of the Nervous
System
Abnormalities were not detected on histopathological
examination of muscle, spinal cord, peripheral nerves,
liver, and kidney tissue in all dogs but 1 (#1). This dog
showed changes consistent with mild, chronic hepatitis
and a mild myopathy characterized by patchy lympho-
cytic inﬁltration and mild variation in myocyte diameter.
Pedigree Analysis
Aﬀected dogs were oﬀspring to unaﬀected parents
(Fig 7). There was no signiﬁcant diﬀerence between
numbers of aﬀected males and females (males 6, females
3 known aﬀected; c.f. 26 males and 20 females total in
aﬀected litters; v2, P = .49) and 28–43% of the dogs in
the litters were reported to be aﬀected. Common ances-
tors on both maternal and paternal lines were frequent,
with all aﬀected dogs having descended from 5 founder
members (data not shown).
Discussion
We report here a novel, progressive encephalopathy
of the NSDTR presenting with REM sleep behavior
disorder, abnormal behavior, and ataxia. MRI of
aﬀected individuals is characterized by symmetrical
T2W hyperintensities of the rostral caudate nuclei, cor-
responding to malacia with neurite swelling on
histopathology. The marked involuntary movements
during sleep have the characteristics of a REM sleep
behavior disorder (also called REM without atonia)14
although polysomnographic recordings were not per-
formed to conﬁrm that the episodes occurred during the
REM phase of sleep. Conﬁrmed or suspected REM
sleep behavior disorders occur in dogs, a minority of
which are associated with concurrent central nervous
system disorders (seizures, ataxia, and anxiety disor-
ders).8–10 MRI in 2 aﬀected dogs was normal.
Experimental models of caudate nucleus ablation in
cats, as well as instances of spontaneous damage to the
caudate nucleus, result in ataxia, apathy,
Fig 4. Cavitation of the caudate nucleus from one of the aﬀected
dogs. The tissue intersecting with the edges of the cavity (asterisks)
are irregular, with astrocyte-rich parenchymal strands crossing the
margin and peripheral astrocytosis (inset, arrows; under 92
greater magniﬁcation) (glial ﬁbrillary acidic protein-positive
immunohistochemistry; hematoxylin counterstain). Original magni-
ﬁcation 409.
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Fig 5. H&E (A and B), Bielschowsky (C and D), phosphorylated neuroﬁlament (E), and calretinin (F) staining showing distended neurites
in the brainstem (trapezoid nucleus, A, C, D, and E; inferior olive, F) and the cerebral cortex (B). Swellings up to 50 lm in diameter occur
in the brainstem (A, C, and E; arrows) and medulla (F; arrows), with irregular shapes and variable intensity characteristic of H&E and
Bielschowsky staining, whereas swellings in the forebrain (B; arrows) were more uniformly and intensely stained. Rarely, there is continuity
between a cell body and swollen neurites (inset, C; arrow), identifying them as axons. In another area of the trapezoid nucleus small swol-
len neurites form haloes (D, arrows) around neuron cell bodies (n). NeuN immunohistochemistry (inset, D; hematoxylin counterstain)
revealed viable neurons (arrow heads) within aﬀected brain nuclei, whereas, as expected, axonal spheroids (arrows) remained unstained.
Immunohistochemical staining for axonal neuroﬁlaments vary in intensity (E; arrows), whereas those detecting calcium-binding proteins
are more consistent (F and inset, F, calbindin staining of a single neurite, cerebellar molecular layer; arrows). Original magniﬁcations 2009
(A and F); 4009 (B, D and E); 1009 (C).
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obsessive-compulsive behavior, cognitive deﬁcits, and
hyperactivity;15 much of which were reported in aﬀected
dogs described within this study. However, REM sleep
behavior disorder is not a feature of caudate nucleus
destruction in cats, and in contrast, hyposomnia was
present.15 In humans, REM sleep behavior anomalies
are often the initial clinical sign in extrapyramidal dis-
eases such as Parkinson’s disease, multiple system atro-
phy, and dementia with Lewy bodies.7 Again, however,
neither degeneration of the substantia nigra or cerebel-
lum, nor Lewy bodies were observed in the NSDTR,
and the pathomechanism of the REM sleep behavior
disorder in this condition remains unknown.
Diﬀerential diagnoses for the bilaterally symmetrical
lesions in the basal nuclei (comprising the caudate
nucleus and putamen) included the following: toxic (e.g.
carbon monoxide, methanol), metabolic, infectious,
immune-mediated, vascular, and neurodegenerative dis-
eases (including multiple systems atrophies).16–18 The
chronic, progressive nature of the disease, and its
worldwide distribution made toxic insult highly unli-
kely. No evidence of other inborn errors of metabolism,
acquired metabolic disease, nutritional deﬁciencies, or
infectious disease were found on clinical pathology and
review of clinical history (including the observation of
simultaneous development of disease on diﬀerent conti-
nents). However, rare hereditary malabsorptive process
or vitamin metabolism disorder19 could not be
excluded. The absence of inﬂammatory inﬁltrates in the
brain tissue made an immune-mediated destruction or
an infectious etiology unlikely. The virtual absence of
hemosiderin and gitter cells in aﬀected NSDTR reduces
the likelihood of an acute vascular etiology. The occur-
rence of nearly identical clinical signs, MRI appearance,
and histopathological ﬁndings in related dogs of the
same breed supported a hereditary neurodegenerative
disorder.
Hereditary neurodegenerative disorders characterized
by bilateral necrosis of gray matter, including the basal
nuclei, occur in dogs. Leigh-like syndrome, or polioen-
cephalomyelopathy, occurs as an autosomal recessive
disease in Australian cattle dogs, American Staﬀord-
shire bull terriers, Alaskan huskies, and Yorkshire terri-
ers.20–23 In contrast to the aﬀected NSDTR described in
this study, aﬀected dogs present with a combination of
seizures, and progressive dysphagia and spastic tetra-
paresis. As in Leigh disease of humans, a mitochondrial
disorder had been suspected; however, a recent study
identiﬁed a mutation in the thiamine transporter 2 gene
(SLC19A3) associated with Leigh-like syndrome in the
Alaskan husky.24 Progressive cavitation of the caudate
nuclei occurs in Kerry Blue terriers and Chinese Crested
dogs with multisystem neurodegeneration.25,26 However,
these changes are preceded by loss of cerebellar Purk-
inje cells, with associated cerebellar ataxia, and are fol-
lowed by neuronal depletion in the substantia nigra.
Necrosis of the basal nuclei also occurred in a young
Shi Tzu with severe neurological signs and a disorder of
fatty acid metabolism.27
Degenerative encephalopathies with necrosis of the
basal nuclei also occur in noncanine species.28,29 Well
characterized human diseases include Huntington’s
disease (autosomal dominant, adult onset), chorea-
acanthocytosis (autosomal recessive; adult onset), infan-
tile bilateral striatal necrosis (autosomal recessive,
neonatal onset), and progressive supranuclear palsy
(adult onset).29–32 However, the heterogeneity of clinical
signs, age of onset, rate of progression, and underlying
pathological mechanism of these diﬀerent neurodegener-
ative diseases reﬂect how nonspeciﬁc basal nuclei mala-
cia is as a ﬁnding.
In addition to the grossly evident cavitation of the
caudate nuclei, locally severe swelling of axons was pre-
sent in all NSDTR examined with histopathology.
Although 2 types of swollen neurites were identiﬁed
with routine histopathology, we further used immuno-
histochemistry to visualize both neuronal projections
and cell bodies. It conﬁrmed the presence of 2 types of
neurite swelling (e.g., with the Bielschowsky and phos-
phorylated neuroﬁlament stains, some swollen neurites
were pale and some were strongly stained) and also
helped to classify the neurites as axons due to their rela-
tionship with neuronal cell bodies. The NeuN stain also
allowed identifying viable neurons despite the extensive
axonal lesions. Finally, calcium-binding proteins, widely
expressed through the central nervous system, were
stained to further assess whether there was depletion of
these molecules which could cause impairment of motor
coordination for example. However, abnormalities were
Fig 6. Astrocytosis associated with swollen axons and their neu-
rons. Arrows denote nearby swollen axons (glial ﬁbrillary acidic
protein-positive; hematoxylin counterstain). Original magniﬁcation
4009.
Fig 7. Pedigree for a cluster of the aﬀected dogs (blue squares/
circles).
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not detected using these staining techniques, although
we did not quantify stained material against controls.
The extent of astrogliosis associated with abnormal
axons, in the absence of concurrent inﬂammatory inﬁl-
tration, and the presence of caudate cavitations are sup-
portive of this being a chronic the disease process, and
it is surprising that the degree of dysfunction was not
more marked in these dogs at the time of euthanasia.
The axonal swellings are consistent with a neuroaxonal
dystrophy (NAD), which could cause the ataxia
observed. NAD is characterized by localized swellings
(spheroids) and axonal atrophy, but is a nonspeciﬁc
ﬁnding and might occur as a progressive hereditary dis-
ease or develop secondary to insults such as vitamin E
deﬁciency, hydrocarbon exposure, and as an age-related
change.33 Ultrastructural studies often show compart-
mentalization in axonal swellings with separation of
neuroﬁlaments and organelles, perhaps accounting for
the variable staining pattern. Fetal-onset and juvenile-
onset NADs, resembling human infantile NAD, occur
in Papillons, Jack Russell terriers, Border Collies,
Rottweilers, and a laboratory colony of crossbreed
dogs.34–38 How the axonal changes relate to the dra-
matic caudate necrosis is unclear as this has not been
described in the reports of NAD. A lysosomal storage
disease cannot be ruled out, due to the progressive nat-
ure of the disease and the presence of PAS-positive
material in the medulla of aﬀected dogs; however, the
marked malacia is not a feature typical of lysosomal
storage disease. There was no evidence of vacuolation
in non-nervous tissue examined, and the medullary
changes were more consistent with axonal dystrophy.
Due to a small number of founder dogs, the NSDTR
has a high inbreeding coeﬃcient (0.26; where 0.25
would equate to the genetic equivalent of a dog
produced from a son to mother mating) and low eﬀec-
tive population size;39 however, in a study of Norwe-
gian NSDTR estimating genetic diversity using
standard canine panels of microsatellite markers, the
level of genetic variation is found to be only slightly
lower than that of many other dog breeds.40 Inbreeding
does not cause hereditary diseases as such, but makes
the expression of recessive traits more likely. Inspection
of pedigrees described herein supported an autosomal
recessive mode of inheritance of the degenerative
encephalopathy. Nine aﬀected dogs were investigated in
this study, and some dogs did not have an exhaustive
work-up to exclude all potential causes of a degenera-
tive encephalopathy. Thus, additional studies would be
needed to completely rule out other causes of the condi-
tion or conﬁrm a hereditary disease by identifying a
variant that cosegregates with the phenotype in a larger
population. As this disease has not been previously
described in animals, this could either represent a recent
de novo mutation within the breed or a failure to associ-
ate the subtle MRI changes with the clinical signs. Iden-
tiﬁcation of the genetic abnormality associated with this
disease could be used to determine the frequency of car-
riers within the population. Identiﬁcation of carriers
would permit breeders to use wise breeding strategies to
avoid aﬀected dogs in the future while maintaining
desirable traits and genetic diversity in the breed.
Footnotes
a www.rasdata.nu/tollare/
b http://www.k9data.com/default.asp?breed=3
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tochemical staining of sections.
Table S2. Summaries of case signalment, reported
clinical signs (general and neurological), physical exami-
nation ﬁndings (general and neurological), clinical tests
performed, advanced imaging ﬁndings, response to
treatment, and outcome.
Video S1. Home video recording of aﬀected NSDTR
demonstrating marked involuntary movements during
sleep.
Video S2. Home video of aﬀected NSDTR demon-
strating abnormal vertical position adopted during
swimming.
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